Q1 2020 Jazz Pharmaceuticals PLC Earnings Call Transcript
Welcome to the Jazz Pharmaceuticals plc First Quarter 2020 Earnings Conference Call. Following an introduction from the company, we will open the call for questions.
I will now turn the call over to Katherine Littrell, Head of Investor Relations at Jazz Pharmaceuticals.
Thank you, Valerie, and thanks to those of you joining our investor call. Today, we reported our first quarter 2020 financial results and updated our financial guidance for 2020. The press release and the slide presentation accompanying this call are available in the Investors section of our website. On the call today are Bruce Cozadd, CEO; Dan Swisher, President; Renée Galá, CFO; Rob Iannone, Executive Vice President, R&D. And then joining for questions, our Q&A session, will include Mike Miller, Executive Vice President, U.S. Commercial; Phil Jochelson, Sleep and Neuroscience Therapeutic Head; Anne Borgman, Hematology and Oncology Therapeutic Head; Jed Black, our Sleep Neuroscience Fellow; and Shawn Mindus, Senior
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |